Learn about the Rich History of PCI

The Penn Gazette wrote an incredible piece about PCI and its role in Penn’s successes in research and innovation over the past decade. Founded in 2014, PCI has since consolidated efforts across the university to create strategic partnerships and move groundbreaking ideas from academia to industry, significantly boosting Penn’s entrepreneurial and innovation capabilities.

The article explains how PCI has enabled Penn faculty to translate their research into marketable products, resulting in record-breaking revenues and establishing the university as a clear leader in innovation.

The article also highlights how PCI provided crucial support in navigating the commercialization process for world-renowned Penn-invented technologies, including CAR T cell therapy and the mRNA technology that made the life-saving COVID-19 vaccines possible.

Download Penn Startups Raising Money List

Learn about which Penn startup companies are raising money in 2024 with this comprehensive list. With companies in connected health, digital health, diagnostics, therapeutics, and medical devices, Penn offers a wide range of rapidly emerging companies at all investment levels.

If you are interested in connecting about these startups, please email Laurie Actman (lactman@upenn.edu).

Discover CAR T-cell technology at Penn

Our latest CAR T-cell enhancement portfolio features innovations poised to transform treatment efficacy with boosted cytokine activity/metabolism, streamlined manufacturing, and reduced T-cell exhaustion. Join us in turning lab discoveries into real-world impact through licensing opportunities with PCI.